{"id":2095109,"date":"2023-11-09T12:28:02","date_gmt":"2023-11-09T17:28:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/weight-loss-drugs-transforming-healthcare-may-help-with-addiction\/"},"modified":"2023-11-09T12:32:11","modified_gmt":"2023-11-09T17:32:11","slug":"weight-loss-drugs-transforming-healthcare-may-help-with-addiction","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/weight-loss-drugs-transforming-healthcare-may-help-with-addiction\/","title":{"rendered":"Weight loss drugs transforming healthcare, may help with addiction"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"float:left\"><div class=\"counts mashsbcount\">18<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fweight-loss-drugs-transforming-healthcare-may-help-with-addiction%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2095109&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><p><!DOCTYPE html PUBLIC \"-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\" \"http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\"><br \/>\n<?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><html><body><\/p>\n<div class=\"entry-content\">\n<p><span class=\"text__text__1FZLe text__dark-grey__3Ml43 text__regular__2N1Xr text__small__1kGq2\" data-testid=\"Text\">By <\/span>Julie Steenhuysen<span class=\"text__text__1FZLe text__dark-grey__3Ml43 text__regular__2N1Xr text__small__1kGq2\" data-testid=\"Text\"> and <\/span>Caroline\u2062 Stauffer<\/p>\n<p>11:28 \u2063AM UTC \u2013 November \u20639,\u200d 2023<\/p>\n<div id=\"div-gpt-ad-1663871513696-art-3\" style=\"min-width: 320px; min-height: 50px; text-align: center;\">  \t<script>  \t\tgoogletag.cmd.push(function() { googletag.display('div-gpt-ad-1663871513696-art-3'); });  \t<\/script>  <\/div>\n<div class=\"ad-slot__ad-label\">Advertisement<\/div>\n<\/p>\n<p><h2>Revolutionary Weight \u2063Loss Drugs Could Transform Healthcare System<\/h2>\n<\/p>\n<p>CHICAGO (Reuters) \u2013 Experts at \u2064the Reuters Events Total Health\u200b conference in Chicago this week revealed that a groundbreaking class of weight\u2063 loss drugs\u2063 is not only changing\u2064 the way obesity is treated, but also has the \u200cpotential to \u2064address other challenging conditions like \u2064substance abuse.<\/p>\n<p>The U.S. Food and Drug Administration recently approved Eli\u2062 Lilly&#8217;s drug tirzepatide, known as \u200cZepbound, for weight\u200b loss. \u2063This drug, belonging to\u2063 the \u200bGLP-1 class, is\u200b already used to treat type 2\u200c diabetes under the brand name Mounjaro. Novo\u2062 Nordisk&#8217;s Wegovy, or \u2063semaglutide, is \u200danother GLP-1 drug approved for obesity and sold \u200cas Ozempic \u200cfor diabetes.<\/p>\n<p>GLP-1 drugs mimic the\u200d action\u200b of the GLP-1 \u2064hormone, regulating blood sugar, slowing digestion, and \u200csuppressing appetite. Studies have shown that Wegovy can\u200b lead to\u2062 a 15% weight loss over 68 weeks, while \u200dLilly&#8217;s drug,\u200d which \u2063also targets the GIP hormone, demonstrated weight loss of over 22% \u200dover 72 weeks.<\/p>\n<p><h3>Potential\u200b for Controlling Addiction and\u200d Lowering Healthcare Costs<\/h3>\n<\/p>\n<p>Lawrence \u2063Tabak, \u2062principal deputy\u200c director at the U.S. National Institutes of Health (NIH),\u200d highlighted the potential \u200dof these drugs \u2064to control addiction and \u200bother metabolic conditions. While acknowledging that more research is needed and \u200dthat \u200cthe drugs have side effects,\u200b Tabak emphasized\u2062 the new possibilities they offer in terms of obesity control\u200b and\u200c overall metabolism.<\/p>\n<p>Walgreens, a\u200c major drugstore chain, has \u200creported &#8220;enormous demand&#8221; for GLP-1 \u200ddrugs. John\u2063 Driscoll, president of U.S. healthcare\u2063 at Walgreens Boots Alliance, believes that \u200bthese drugs will revolutionize healthcare, although insurance reimbursement has not yet\u200c caught up with the demand.<\/p>\n<p>It is worth noting that these drugs \u2063have\u200c a \u200bhigh price tag, with monthly costs exceeding $1,000. However, Tabak suggests that as time goes on, the\u200b prices \u2063may decrease, \u200cand the potential for <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/weight-loss-drugs-transforming-healthcare-may-help-with-addiction\/\" title=\"Weight loss drugs transforming healthcare, may help with addiction\">lower healthcare costs due<\/a> to reduced cardiovascular disease and related conditions should be considered.<\/p>\n<p><h3>Looking\u2062 Beyond \u2062Obesity<\/h3>\n<\/p>\n<p>While the impact \u200cof these weight\u200c loss drugs on consumer habits like snack food purchases\u2063 remains to be seen, Driscoll believes that\u2063 understanding their \u200dpotential \u2064goes beyond just addressing obesity. He stated that \u200dWalgreens is ready to adapt to \u200dconsumer preferences and that \u2064they are \u2062just scratching the surface \u200cof what these \u2063drugs \u2064can achieve.<\/p>\n<p>Reporting by\u200c Julie Steenhuuysen and Caroline\u2062 Stauffer; Writing by Deena Beasley; Editing by Jamie Freed<\/p>\n<\/p>\n<div id=\"rc-widget-10bad2\" data-rc-widget data-widget-host=\"habitat\" data-endpoint=\"\/\/trends.revcontent.com\" data-widget-id=\"278641\"><\/div>\n<p class=\"dpsp-share-text\" style=\"margin-bottom:10px\"> \t\t \t\tShare this post!\t<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>with Rep. \u2063Ralph Norman<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>with Dr. Pierre\u200d Kory<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>with Dustin\u200b Olson<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>with Leo Hohmann<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>An adviser to Europe\u2019s top court said an EU tribunal made\u200c legal errors\u200c when it ruled in favor of \u200bApple.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>Zeekr will \u2062this week \u2062publicly \u2062release some\u2063 details of its plans to list shares in New York.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>Top\u2064 EU court backs Google, Meta, \u2062and TikTok against Austrian law mandating hate speech deletion.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>Amazon to invest millions \u200din Olympus \u200bLLM model to rival OpenAI and \u2062Alphabet.<\/p>\n<\/p><\/div>\n<p> rnrn  <\/p>\n<h2> How do GLP-1 drugs like tirzepatide and Wegovy revolutionize the treatment of\u200b obesity and address other challenging conditions?<\/h2>\n<p><span>  \u200d Significant potential \u200bto not only transform the healthcare system but also address challenging conditions such as substance abuse. The groundbreaking class of weight loss drugs,\u2063 specifically GLP-1 drugs, is revolutionizing the \u200dway obesity is treated.<\/p>\n<p>One\u200c of the recently\u2063 approved drugs is Eli Lilly&#8217;s tirzepatide, known as Zepbound, which has been approved by the U.S. Food and Drug Administration for weight loss. This drug belongs to the GLP-1 class and \u2062is already used to treat type\u200d 2 diabetes\u2062 under the brand name Mounjaro. Another \u2063GLP-1 drug approved for obesity is Novo Nordisk&#8217;s Wegovy,\u2062 or semaglutide, sold as Ozempic for diabetes.<\/p>\n<p>GLP-1 drugs work by mimicking the action of the GLP-1 hormone, which regulates \u2063blood sugar, slows digestion, and\u200c suppresses appetite. Studies\u200c have shown that Wegovy can \u2062lead to\u200c a 15%\u2062 weight loss over\u200c 68 weeks, \u200bwhile\u200d Eli Lilly&#8217;s drug, which also targets the GIP hormone, demonstrated weight loss of over 22% over 72 weeks.<\/p>\n<p>However, the potential of these drugs goes beyond weight loss.\u200b Lawrence Tabak, the <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/biden-considering-not-giving-trump-intelligence-briefings\/\" title=\"Biden Considering Not Giving Trump Intelligence Briefings\">principal deputy director<\/a> at the U.S. National Institutes of Health (NIH), highlighted the drugs&#8217; potential to control addiction and other metabolic \u200cconditions. While further research \u2062is \u200cneeded and these drugs\u2064 have side \u200beffects, Tabak emphasized the new\u2063 possibilities they offer in terms of obesity\u2063 control \u200cand overall metabolism.<\/p>\n<p>The demand for GLP-1 drugs is already\u200c high, with major drugstore chain Walgreens reporting &#8220;enormous demand.&#8221; John Driscoll, president of U.S. healthcare at Walgreens Boots \u2062Alliance, believes that these \u200ddrugs will revolutionize healthcare. \u200cHowever, insurance reimbursement has not yet caught \u200cup with the demand, posing a challenge.<\/p>\n<p>In conclusion, the emergence of revolutionary weight loss drugs, specifically GLP-1 drugs, is transforming the \u200bhealthcare system. \u200dThese drugs not\u2064 only offer a promising solution to obesity but also have the potential to address\u200b other challenging conditions like \u200dsubstance abuse. While further research \u200dis needed and challenges such\u2064 as insurance reimbursement exist, the potential benefits these \u2064drugs offer are significant. \u2064The healthcare \u200bindustry must continue to explore the possibilities\u2063 presented by these drugs and work towards making them\u200d accessible to all who can benefit from them.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>By\u00a0Julie Steenhuysen\u00a0and\u00a0Caroline Stauffer 11:28 AM UTC \u2013 November 9, 2023 Advertisement CHICAGO (Reuters) \u2013 A new class of weight loss drugs is transforming the U.S. healthcare system in ways that could extend to equally hard-to-treat areas like substance abuse, according to speakers at the Reuters Events Total Health conference in Chicago this week. The U.S.<\/p>\n","protected":false},"author":1911,"featured_media":2095110,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[542],"tags":[],"class_list":["post-2095109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oann"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2095109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1911"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2095109"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2095109\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2095110"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2095109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2095109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2095109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}